Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Mar;18(1):210174.
doi: 10.1183/20734735.0174-2021. Epub 2021 Mar 8.

Reply to: Challenging the paradigm

Affiliations
Comment

Reply to: Challenging the paradigm

Andrew Bush et al. Breathe (Sheff). 2022 Mar.

Abstract

Inhaled corticosteroids should be targeted to those with documented airway eosinophilia, not prescribed indiscriminately to all who wheeze. Blind steroid treatment without regard to underlying pathophysiology is not 21st century standard of care. https://bit.ly/34lyaJG.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: A. Bush has nothing to disclose. Conflict of interest: I.D. Pavord reports speaker fees from Aerocrine AB; speaker fees and consultant fees from Almirall and Novartis; speaker fees, payments for organisation of educational events, consultant fees and international scientific meeting sponsorship from AstraZeneca, GSK, Regeneron Pharmaceuticals, Inc, Sanofi, Teva; speaker fees, consultant fees and international scientific meeting sponsorship from Boehringer Ingelheim; grants, speaker fees, consultant fees and international scientific meeting sponsorship from Chiesi; consultant fees from Circassia, Dey Pharma, Genentech, Knopp Biosciences, Merck, MSD, RespiVert, Schering-Plough; and consultant fees and international scientific meeting sponsorship from Napp Pharmaceuticals, outside the submitted work.

Comment on

References

    1. Bush A, Pavord ID. Challenging the paradigm: moving from umbrella labels to treatable traits in airway disease. Breathe 2021; 17: 210053. doi:10.1183/20734735.0053-2021 - DOI - PMC - PubMed
    1. Bush A, Fleming L, Saglani S. Severe asthma in children. Respirology 2017; 22: 886–897. doi:10.1111/resp.13085 - DOI - PubMed
    1. Cook J, Beresford F, Fainardi V, et al. . Managing the paediatric patient with refractory asthma: a multidisciplinary approach. J Asthma Allergy 2017; 10: 123–130. doi:10.2147/JAA.S129159 - DOI - PMC - PubMed
    1. Saglani S, Fleming L, Sonnappa S, et al. . Advances in the aetiology, management, and prevention of acute asthma attacks in children. Lancet Child Adolesc Health 2019; 3: 354–364. doi:10.1016/S2352-4642(19)30025-2 - DOI - PubMed
    1. Pavord ID, Beasley R, Agusti A, et al. . After asthma: redefining airways diseases. Lancet 2018; 391: 350–400. 10.1016/S0140-6736(17)30879-6. - DOI - PubMed

LinkOut - more resources